This looks like the big Covid news for the day, Moderna has asked the FDA for an Emergency Use Authorization for its pediatric formulation of its Covid-19 vaccine.
According to the Politico story linked above:
The request, which POLITICO first reported late Wednesday, comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults, and amid growing impatience from lawmakers and parents for the administration to green-light a vaccine for the nation’s youngest children.
So that’s good news for parents of young kids. The bad news is the FDA wants to do a little more foot dragging, just to be sure — I don’t know — that their shoes are broken in or something.
Under questioning Tuesday from Sen. Patty Murray (D-Wash.), top FDA vaccine regulator Peter Marks told lawmakers that the agency planned to publish a tentative timeline next week showing when it planned to hold outside advisory committee meetings on the vaccines for young children — a move that could offer more precise insight into when the agency plans to authorize the shots
Last week, Politico had reported that the FDA was waiting on Pfizer and Moderna to both get their applications in so they could make their decision on both vaxes at the same time so as to “not confuse parents” (but maybe infuriate them . . .) If I can editorialize a bit, I don’t think parents who are wanting to get their youngest children vaccinated as soon as possible are likely to be tuning in to this news just now, but rather have been following developments quite closely.